Armistice Capital, LLC’s Ptc Therapeutics Inc Position
Does Armistice Capital, LLC own Ptc Therapeutics Inc (PTCT)? Yes — 2.07M shares worth $141M (+2.51% of its 13F portfolio) as of Q1 2026, down from 2.80M shares the prior filed quarter.
Position Value
$141M
Q1 2026
Shares
2.07M
% of Portfolio
+2.51%
Quarters Held
25
currently held
Position History PTCT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.07M | $141M | +2.51% |
| Q4 2025 | 2.80M | $213M | +2.53% |
| Q3 2025 | 3.28M | $201M | +2.98% |
| Q2 2025 | 4.74M | $231M | +3.99% |
| Q1 2025 | 5.43M | $277M | +4.15% |
| Q4 2024 | 6.38M | $288M | +3.93% |
| Q3 2024 | 7.23M | $268M | +4.29% |
| Q2 2024 | 6.96M | $213M | +2.68% |
| Q1 2024 | 6.76M | $197M | +2.61% |
| Q4 2023 | 6.86M | $189M | +2.58% |
| Q3 2023 | 6.15M | $138M | +2.11% |
| Q2 2023 | 3.24M | $132M | +1.90% |
| Q1 2023 | 2.92M | $142M | +2.04% |
| Q4 2022 | 3.40M | $130M | +2.26% |
| Q3 2022 | 2.90M | $146M | +2.53% |
| Q2 2022 | 3.30M | $132M | +2.30% |
| Q1 2022 | 3.04M | $113M | +2.19% |
| Q4 2021 | 917.1K | $37M | +0.60% |
| Q3 2021 | 2.60M | $97M | +1.64% |
| Q2 2021 | 2.09M | $88M | +1.58% |
| Q1 2021 | 1.40M | $66M | +1.52% |
| Q4 2020 | 716.0K | $44M | +1.96% |
| Q3 2020 | 724.0K | $34M | +1.23% |
| Q2 2020 | 500.0K | $25M | +1.11% |
| Q1 2020 | 600.0K | $27M | +1.66% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Armistice Capital, LLC’s full portfolio or all institutional holders of PTCT.